Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis-Claude Roy

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Transplantation and Cellular Therapy|December 26, 2021
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian PerspectiveOlivier Veilleux, Jean-Sébastien Claveau, Habiba Alaoui, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center ExperienceEva Laverdure, Luigina Mollica, Imran Ahmad, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 26, 2016
The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133<sup>+</sup> stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathyNicolas Noiseux, Samer Mansour, Richard Weisel, et al.
Transplantation and Cellular Therapy|October 15, 2022
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies EmergeSylvie Lachance, Alex Bourguignon, Josie-Anne Boisjoly, et al.
Bone Marrow Transplantation|November 30, 2021
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II studyRichard LeBlanc, Imran Ahmad, Rafik Terra, et al.
Transfusion|January 29, 2025
Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case reportMathias Castonguay, Léa Bernard, Marylène Corriveau, et al.
BMC Medical Ethics|February 4, 2014
Policy recommendations for addressing privacy challenges associated with cell-based research and interventionsUbaka Ogbogu, Sarah Burningham, Adam Ollenberger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016Monzr M Al Malki, Richard Jones, Qing Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2016
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014Monzr M Al Malki, Mary Horowitz, Rupert Handgretinger, et al.
Science (New York, N.Y.)|September 20, 2014
Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewalIman Fares, Jalila Chagraoui, Yves Gareau, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Transplantation and Cellular Therapy|December 26, 2021
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian PerspectiveOlivier Veilleux, Jean-Sébastien Claveau, Habiba Alaoui, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center ExperienceEva Laverdure, Luigina Mollica, Imran Ahmad, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 26, 2016
The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133<sup>+</sup> stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathyNicolas Noiseux, Samer Mansour, Richard Weisel, et al.
Transplantation and Cellular Therapy|October 15, 2022
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies EmergeSylvie Lachance, Alex Bourguignon, Josie-Anne Boisjoly, et al.
Bone Marrow Transplantation|November 30, 2021
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II studyRichard LeBlanc, Imran Ahmad, Rafik Terra, et al.
Transfusion|January 29, 2025
Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case reportMathias Castonguay, Léa Bernard, Marylène Corriveau, et al.
BMC Medical Ethics|February 4, 2014
Policy recommendations for addressing privacy challenges associated with cell-based research and interventionsUbaka Ogbogu, Sarah Burningham, Adam Ollenberger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016Monzr M Al Malki, Richard Jones, Qing Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2016
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014Monzr M Al Malki, Mary Horowitz, Rupert Handgretinger, et al.
Science (New York, N.Y.)|September 20, 2014
Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewalIman Fares, Jalila Chagraoui, Yves Gareau, et al.
Pageof 8